E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers D > Headlines for Dishman Pharmaceuticals & Chemicals Ltd. > News item
Published on 5/16/2006 in the Prospect News Biotech Daily.

Dishman to use $60 million loan proceeds to fund European acquisitions

By Lisa Kerner

Erie, Pa., May 16 - Dishman Pharmaceuticals & Chemicals Ltd. said it has secured a syndicated loan up to $60 million with ICICI Bank.

Proceeds will be used to fund the potential acquisition in Europe, according to a news release.

Dishman, based in Ahmedabad, India, manufactures active pharmaceutical ingredients and chemicals


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.